Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6881208 | THE MEDICINES CO | Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
Apr, 2022
(1 year, 5 months ago) | |
US6975902 | THE MEDICINES CO | Reservoir and a series of related reservoirs for use in an electrotransport drug delivery device and devices comprised thereof |
Apr, 2024
(6 months from now) | |
US8301238 | THE MEDICINES CO | Two-part electrotransport device |
Sep, 2031
(8 years from now) | |
US9364656 | THE MEDICINES CO | Method of storing an electrotransport drug delivery device |
Sep, 2031
(8 years from now) | |
US9731121 | THE MEDICINES CO | Switch validation circuit and method |
Oct, 2031
(8 years from now) | |
US8781571 | THE MEDICINES CO | Switch validation circuit and method |
Mar, 2032
(8 years from now) | |
US8428708 | THE MEDICINES CO | Self-test for analgesic product |
May, 2032
(8 years from now) | |
US8428709 | THE MEDICINES CO | Current control for electrotransport drug delivery |
Jun, 2032
(8 years from now) | |
US9095706 | THE MEDICINES CO | Self-test for analgesic product |
Feb, 2033
(9 years from now) |
Ionsys is owned by The Medicines Co.
Ionsys contains Fentanyl Hydrochloride.
Ionsys has a total of 9 drug patents out of which 1 drug patent has expired.
Expired drug patents of Ionsys are:
Ionsys was authorised for market use on 22 May, 2006.
Ionsys is available in system;iontophoresis, transdermal dosage forms.
Ionsys can be used as method for iontophoretic transdermal delivery of fentanyl hydrochloride.
The generics of Ionsys are possible to be released after 03 February, 2033.
Drugs and Companies using FENTANYL HYDROCHLORIDE ingredient
Market Authorisation Date: 22 May, 2006
Treatment: Method for iontophoretic transdermal delivery of fentanyl hydrochloride
Dosage: SYSTEM;IONTOPHORESIS, TRANSDERMAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic